Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
---|---|---|---|---|---|
FUSION PHARMACEUTICALS | 14 | 14 | 0,00 % | ||
MADRIGAL PHARMACEUTICALS | 11 | 51 | -0,73 % | ||
MIRUM PHARMACEUTICALS | 5 | 15 | +0,83 % | ||
CRINETICS PHARMACEUTICALS | 5 | 10 | +14,86 % | ||
BLUEBIRD BIO | 5 | 7 | +1,23 % | ||
SCHOLAR ROCK | 5 | 5 | -1,64 % | ||
ARVINAS | 5 | 5 | 0,00 % | ||
BIONTECH | 4 | 31 | +0,12 % | ||
ALPINE IMMUNE SCIENCES | 4 | 4 | -0,61 % | ||
CUREVAC | 3 | 17 | -0,84 % |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
13:24 | AstraZeneca-Fusion deal reignites radiopharma space | - | Seeking Alpha | ||
13:18 | Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket | 1 | Benzinga.com | ||
13:15 | Biotech Stock Crinetics Jets Higher On Second Phase 3 Trial Win | 1 | Investor's Business Daily | ||
13:12 | ClearPoint Neuro, Inc.: ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza as a Treatment for AADC Deficiency | 58 | GlobeNewswire (Europe) | SOLANA BEACH, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen | |
13:10 | US STOCKS National Cinemedia, Madrigal Pharmaceuticals, dLocal | 1 | Reuters | ||
13:10 | bluebird (BLUE) Gets $175 Million Loan From Hercules, Shares Up | 1 | Zacks | ||
13:06 | Morphic Therapeutic: Morphic Appoints Dr. Simon Cooper as Chief Medical Officer | 16 | GlobeNewswire (Europe) | WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious... ► Artikel lesen | |
13:06 | 23andMe, Inc.: 23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago | 1 | GlobeNewswire (USA) | ||
13:02 | BioNTech: Morgen Zahlen - das können Anleger erwarten | 185 | Der Aktionär | Morgen ist es soweit: Das Mainzer Biotech-Unternehmen BioNTech veröffentlicht gegen Mittag die Zahlen zum vierten Quartal sowie zum Gesamtjahr 2023. Es wird spannend, ob das Management hier bereits... ► Artikel lesen | |
13:01 | Why Is Fusion Pharmaceuticals (FUSN) Stock Up 101% Today? | 1 | InvestorPlace | ||
12:59 | PTC Therapeutics Submits BLA To FDA For Upstaza | - | RTTNews | ||
12:44 | Scholar Rock Holding Corp - S-8, Securities to be offered to employees in employee benefit plans | 5 | SEC Filings | ||
12:33 | Prozessmanagement in der Gemeinschaftsverpflegung / Keros Consult optimiert Warenwirtschaft für Eichhof-Stiftung Lauterbach | 120 | news aktuell | Düsseldorf (ots) - Ab sofort unterstützt Keros Consult, eine hundertprozentige Tochtergesellschaft der Klüh-Gruppe, die Eichhof-Stiftung Lauterbach bei der Optimierung ihrer Bestell- und Produktionsprozesse... ► Artikel lesen | |
12:30 | AstraZeneca's $2.4B Fusion Pharmaceuticals' Acquisition Signals Shift In Efforts From Traditional Regimens For More Targeted Cancer Treatments | 2 | Benzinga.com | ||
12:30 | PTC Therapeutics, Inc.: PTC Therapeutics Provides Key Regulatory Updates | 30 | PR Newswire | - BLA submitted to FDA for Upstaza for the treatment of AADC deficiency -
- NDA to be submitted mid-year for Translarna based on FDA feedback -
SOUTH PLAINFIELD, N.J., March 19, 2024 /PRNewswire/... ► Artikel lesen | |
12:26 | AstraZeneca melds with Fusion in $2B radiopharma buyout | 2 | FierceBiotech | ||
12:22 | Madrigal Pharma secures upsized $600 million equity raise, shares drop | 1 | Reuters | ||
12:22 | Crinetics jumps on success of late-stage treatment trial for hormonal disorder | 1 | Reuters | ||
12:18 | Scholar Rock GAAP EPS of -$1.99 in-line | 4 | Seeking Alpha | ||
12:17 | Scholar Rock Holding Corp - 10-K, Annual Report | 3 | SEC Filings |